Nymox Pharmaceutical Corp (NASDAQ:NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Recs

0
Player Avatar fiona53 (< 20) Submitted: 2/18/2007 4:03:24 AM : Outperform Start Price: $5.70 NYMX Score: +37.36

very interesting pipeline

Featured Broker Partners


Advertisement